{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T00:09:19Z","timestamp":1759018159653,"version":"3.44.0"},"reference-count":6,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.jinf.2015.01.002","type":"journal-article","created":{"date-parts":[[2015,1,9]],"date-time":"2015-01-09T02:19:36Z","timestamp":1420769976000},"page":"546-547","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Recurrent cellulitis and the role of pentraxin 3 and C-reactive protein"],"prefix":"10.1016","volume":"70","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3495-3654","authenticated-orcid":false,"given":"Mehmet","family":"Agilli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fevzi Nuri","family":"Aydin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinf.2015.01.002_bib1","article-title":"Predictors of recurrent cellulitis in five years. Clinical risk factors and the role of PTX3 and CRP","author":"Karppelin","year":"2014","journal-title":"J Infect"},{"key":"10.1016\/j.jinf.2015.01.002_bib2","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.etp.2011.07.003","article-title":"Pentraxin 3 as a potential biomarker of acetaminophen-induced liver injury","volume":"65","author":"Yaman","year":"2013","journal-title":"Exp Toxicol Pathol"},{"key":"10.1016\/j.jinf.2015.01.002_bib3","doi-asserted-by":"crossref","first-page":"725102","DOI":"10.1155\/2013\/725102","article-title":"Long pentraxin 3: experimental and clinical relevance in cardiovascular diseases","volume":"2013","author":"Bonacina","year":"2013","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.jinf.2015.01.002_bib4","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1016\/j.numecd.2014.08.011","article-title":"Pentraxin 3 (PTX3) plasma levels and carotid intima media thickness progression in the general population: a methodological approach","volume":"24","author":"Agilli","year":"2014","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.jinf.2015.01.002_bib5","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/MCA.0b013e328352ffec","article-title":"Plasma pentraxin-3 levels are associated with coronary plaque vulnerability and are decreased by statin","volume":"23","author":"Iwata","year":"2012","journal-title":"Coron Artery Dis"},{"key":"10.1016\/j.jinf.2015.01.002_bib6","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jneuroim.2014.03.014","article-title":"Increasing serum levels of vitamin A, D and E are associated with alterations of different inflammation markers in patients with multiple sclerosis","volume":"271","author":"Rosjo","year":"2014","journal-title":"J Neuroimmunol"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445315000195?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445315000195?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:21:17Z","timestamp":1759008077000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445315000195"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":6,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S0163445315000195"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2015.01.002","relation":{},"ISSN":["0163-4453"],"issn-type":[{"type":"print","value":"0163-4453"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recurrent cellulitis and the role of pentraxin 3 and C-reactive protein","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2015.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2014.11.002","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The British Infection Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}